Beyond ISS staging: the prognostic value of the Inflammation Prognostic Score Index (IPSI) in multiple myeloma
As an independent prognostic index that integrates RDW, PLT, and NMLR, IPSI optimizes ISS staging and provides a cost-effective risk stratification tool. It may be a good measure indice of identifying high-risk MM patients in resource constraint setting where access to molecular testing is not available.
Authors
- Xiaomei Huang (ORCID: https://orcid.org/0000-0002-8567-2708)
- Xunjun Huang
- Qinglan Lu
- Shiying Li (ORCID: https://orcid.org/0000-0001-9783-9520)
- Ruolin Li (ORCID: https://orcid.org/0000-0002-9835-4987)
- Jing Wu
Institutions
- Social Welfare Department (HK)
- First Affiliated Hospital of GuangXi Medical University (CN)
- Baise University (CN)
Publication Details
- Journal
- Hematology
- Published
- 2025-09-01
- DOI
- https://doi.org/10.1080/16078454.2025.2549959
- Primary Topic
- Multiple Myeloma Research and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00